Loading...
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.
Joseph, Nuradh Dovedi, Simon J Thompson, C Lyons, Jeanette Kennedy, J Elliott, Tony West, Catharine M L Choudhury, Ananya
Joseph, Nuradh
Dovedi, Simon J
Thompson, C
Lyons, Jeanette
Kennedy, J
Elliott, Tony
West, Catharine M L
Choudhury, Ananya
Citations
Altmetric:
Abstract
Pre-treatment lymphocytopaenia may result from cytokines secreted by the tumour microenvironment in association with aggressive tumour biology. We sought to establish the prognostic significance of lymphocytopaenia in muscle invasive and advanced bladder cancer.
Description
Date
2015-11-16
Publisher
Collections
Files
Loading...
Open Access Full Text
Adobe PDF, 159.6 KB
Keywords
Type
Article
Citation
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer. 2015: Ann Oncol